{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:54:51Z","timestamp":1788555291067,"version":"build-2803163510"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, topical Tranexamic acid (TXA) has been used in melasma management. On detail search of literature, this may be the first study\u2010assessing efficacy on combining of Topical TXA with GA peel in melasma. The aim of this study is to assess efficacy, safety, and improvement in quality of life index on combining 30% GA peel with 5% TXA solution topically in melasma of epidermal type. Sixty patients of epidermal melasma were included in the study and were categorized into two groups: Combination group was treated with 30% GA peel at 2 weekly intervals with 5% TXA solution applied twice daily and Control group was treated with only 30% GA peel every 2\u2009weeks for 12\u2009weeks. Melasma area severity index (MASI) was used for assessing clinical improvement. Hi\u2010MELASQOL and HRQOL scales were used to measure Melasma related quality of life and were compared between both groups. At each visit, adverse effects were noted. A significantly decreasing trend was seen regarding the MASI score when compared within the group, but the difference was statistically not significant between the two groups at 12\u2009weeks. However, significant reduction in MASI score was attained earlier in the combination group than the control group. Similarly, there was significant improvement in Hi\u2010MELASQOL and HRQOL in both the groups, but the difference between them was statistically not significant. Side effects experienced by patients in both groups were trivial and did not require stoppage of therapy. This study concluded that topical TXA with GA peel has comparable result with GA peel alone, but the therapeutic response was achieved in patients of combination group earlier in comparison to control group patients.<\/jats:p>","DOI":"10.1111\/dth.15107","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T05:17:26Z","timestamp":1629695846000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Topical 5% tranexamic acid with 30% glycolic acid peel: An useful combination for accelerating the improvement in melasma"],"prefix":"10.1155","volume":"34","author":[{"given":"Priyadarshini","family":"Sahu","sequence":"first","affiliation":[{"name":"Department of Dermatology Venereology and Leprology, Pt. B. D. Sharma University of Health Sciences  Rohtak India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-6731","authenticated-orcid":false,"given":"Surabhi","family":"Dayal","sequence":"additional","affiliation":[{"name":"Department of Dermatology Venereology and Leprology, Pt. B. D. Sharma University of Health Sciences  Rohtak India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Dermatology department Skin clinic  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.12.046"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0194-1"},{"key":"e_1_2_9_4_1","first-page":"578","article-title":"Chemical peels in Melasma: a review with consensus recommendations by Indian pigmentary expert group","volume":"62","author":"Sarkar R","year":"2017","journal-title":"Indian J Dermatol"},{"key":"e_1_2_9_5_1","first-page":"5","article-title":"Standard guidelines of care for chemical peels","volume":"74","author":"Khunger N","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12260"},{"key":"e_1_2_9_7_1","first-page":"8","article-title":"Clinical efficacy and safety on combining 20% trichloroacetic acid peel with topical 5% ascorbic acid for melasma","volume":"11","author":"Dayal S","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.66602"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30212.x"},{"key":"e_1_2_9_10_1","first-page":"73","article-title":"Tranexamic acid for Melasma: evaluating the various formulations","volume":"12","author":"Wang JV","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_9_11_1","first-page":"753","article-title":"Topical tranexamic acid as a promising treatment for melasma","volume":"19","author":"Ebrahimi B","year":"2014","journal-title":"J Res Med Sci"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.168937"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S34029"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms11062566"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01074.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12026"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2012.685478"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23032"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.118403"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2005.00287.x"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.15107","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.15107","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.15107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T12:11:10Z","timestamp":1713960670000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.15107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1111\/dth.15107"],"URL":"https:\/\/doi.org\/10.1111\/dth.15107","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"assertion":[{"value":"2021-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15107"}}